Table 3.
Multivariate models identifying risk factors for sleep disturbance at pre-diagnosis as well as 10 and 24 months post-diagnosis (WCHFS, 2012 – 2019)
| Pre-Diagnosis (n=637) |
10 Months Post-Diagnosis (n=261) |
24 Months Post-Diagnosis (n=632) |
||||
|---|---|---|---|---|---|---|
| Predictor/Variable | ||||||
| Estimate (95% Cl) | p | Estimate (95% Cl) | p | Estimate (95% Cl) | p | |
| Education | <.01 | .32 | ||||
| < High school | Referent | Referent | ||||
| Some college | 1.48(1.001–2.20) | 0.80(0.52–1.22) | ||||
| College or grad degree | 0.71 (0.48–1.05) | 0.70(0.44–1.13) | ||||
| Insurance Status | .04 | |||||
| None | Referent | |||||
| Medicaid | 0.21 (0.07–0.65) | |||||
| Medicare | 0.39(0.14–1.07) | |||||
| Private/Other | 0.55(0.24–1.30) | |||||
| Treated with Chemotherapy | .04 | |||||
| No | Referent | |||||
| Yes | 1.76(1.03–3.03) | |||||
| Treated with Endocrine Therapy | .13 | |||||
| No | Referent | |||||
| Yes | 0.67(0.39–1.13) | |||||
| Age (years) | «.01 | |||||
| <50 | Referent | |||||
| 50–60 | 1.03(0.67–1.60) | |||||
| >60 | 0.53 (0.35–0.80) | |||||
| Annual Household Income | .26 | |||||
| < $25,000 | Referent | |||||
| $25,000 - $69,000 | 0.71 (0.46–1.10) | |||||
| > $70,000 | 0.71 (0.44–1.15) | |||||
| BMI at 24 Months Post-Diagnosis | .03 | |||||
| <25 | Referent | |||||
| 25–29 | 0.85(0.49–1.48) | |||||
| >30 | 1.44(0.87–2.40) | |||||
| Lymphedema at 24 Months | <.01 | |||||
| No | Referent | |||||
| Yes | 3.13(1.34–7.30) | |||||
Note: BMI calculated as (Kg/m2). Risk factors were included if they were associated with sleep disturbance at the respective assessment.